Junyan Gu, MD
Vascular Surgery · Hagerstown, MDNPI 1144514340
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,509 of the $10,385 with a category attached, or 72.3%. 34 manufacturers reported payments, led by Medtronic at 37.9% of the total. Reporting peaked in 2022 at $3,230 and has fallen 59.1% since, to $1,322 in 2025.
Across 245 payments — averaging $42.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$4K
- W. L. Gore & Associates, Inc.$1K
- Tactile Systems Technology Inc$903
- Abbott$721
- Boston Scientific$491
- Cook Medical LLC$453
- plus $3K from 28 others
What the payments were for
- Travel & lodging$2,56125%
- Food & beverage$7,50972%
- Education$3153%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 54 | $3,932 |
| W. L. Gore & Associates, Inc. | 18 | $1,074 |
| Tactile Systems Technology Inc | 51 | $903 |
| Abbott | 6 | $721 |
| Boston Scientific | 7 | $491 |
| Cook Medical LLC | 9 | $453 |
| Silk Road Medical, Inc. | 6 | $444 |
| Pfizer | 19 | $271 |
| Johnson & Johnson | 10 | $240 |
| AbbVie | 11 | $197 |
| Inari Medical, Inc. | 1 | $191 |
| Smith+Nephew | 8 | $137 |
| Philips North America LLC | 4 | $125 |
| Endologix LLC | 1 | $117 |
| Checkpoint Surgical, Inc | 1 | $115 |
| Bard Peripheral Vascular, Inc. | 3 | $113 |
| Shockwave Medical, Inc | 2 | $106 |
| E.r. Squibb & Sons, L.L.C. | 5 | $89 |
| Integra Lifesciences Corporation | 3 | $74 |
| Organogenesis Inc. | 3 | $70 |
| Cashflow Solutions, LLC | 4 | $69 |
| Getinge USA Sales, LLC | 1 | $55 |
| Stryker | 2 | $49 |
| Penumbra, Inc. | 1 | $46 |
| Lemaitre Vascular, Inc. | 3 | $45 |
| Coopersurgical, Inc. | 1 | $39 |
| Cordis US CORP. | 1 | $38 |
| Paratek Pharmaceuticals, Inc. | 2 | $35 |
| Bolton Medical Inc | 2 | $33 |
| Surmodics, Inc. | 1 | $28 |
| Kerecis Limited | 2 | $27 |
| Terumo Medical Corporation | 1 | $26 |
| Livanova USA, Inc. | 1 | $17 |
| Angiodynamics, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENDURANT IIS$1,240
- Abre$1,012
- ENROUTE Transcarotid Neuroprotection System$477
- Omnilink Elite vascular stent system$429
- FLOWTRIEVER CATHETER, S$381
- ENROUTE Transcarotid Stent$365
- Endurant$354
- GORE VIABAHN Endoprosthesis with Heparin$293
- GENERAL VASCULAR I$247
- SUPERA$236
- GORE VIABAHN VBX Balloon Expandable Endo$137
- GORE EXCLUDER AAA Endoprosthesis$136
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$124
- Alto Abdominal Stent Graft System$117
- Checkpoint Stimulators$115
- ENHANCE Transcarotid Peripheral Access Kit$112
- ENROUTE .014 Guidewire$112
- Zenith$109
- XARELTO$106
How this compares
$10,385 in reported general payments places this provider in the 75th percentile of 104 vascular surgery providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 98 | $73,905 |
| EliquisApixaban | 11 | $5,781 |
| Cilostazol | 327 | $5,578 |
| Pentoxifylline | 145 | $4,125 |
| ClopidogrelClopidogrel Bisulfate | 190 | $1,993 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 52 | $335 |
| Doxycycline Hyclate | 12 | $81 |
| Oxycodone Hcl | 23 | $69 |
| Tramadol Hcl | 12 | $18 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $240 | $73,90598 claims |
| PfizerEliquis | $271 | $5,78111 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 104 vascular surgery providers in Maryland.
Other vascular surgery in Hagerstown
- William SuHagerstown$9K
- Paul McNeillFrederick$302K
- John MartinAnnapolis$172K
- Caitlin HicksBaltimore$88K
- Shahab ToursavadkohiBaltimore$76K
- Michael OsgoodBel Air$57K
- Jeffrey WangGermantown$53K
- Frank CriadoBaltimore$52K
- Dustin YoonGermantown$36K
- Micah GirottiBel Air$35K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.